HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

4-Pentynoic acid → 4-[4-(2-Oxazolin-2-yl) benzylidene]-1-(4-pentynoyl)piperidine

HRID 129090
Notes
Print preview

Reaction equation

HRID 129090 reaction equation
[C:1]([OH:7])(=O)[CH2:2][CH2:3][C:4]#[CH:5].[O:8]1[CH2:12][CH2:11][N:10]=[C:9]1[C:13]1[CH:25]=[CH:24][C:16]([CH:17]=[C:18]2[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]2)=[CH:15][CH:14]=1>O1CCCC1>[O:8]1[CH2:12][CH2:11][N:10]=[C:9]1[C:13]1[CH:14]=[CH:15][C:16]([CH:17]=[C:18]2[CH2:19][CH2:20][N:21]([C:1](=[O:7])[CH2:2][CH2:3][C:4]#[CH:5])[CH2:22][CH2:23]2)=[CH:24][CH:25]=1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

4

Reactant 2

HCID 224644-Pentynoic acidHCID 152314034-[4-(2-Oxazolin-2-yl)benzylidene]piperidine

Product 1

HCID 152314064-[4-(2-Oxazolin-2-yl) benzylidene]-1-(4-pentynoyl)piperidine

Reagents, catalysts & solvents 1

HCID 8028TetrahydrofuranSolvent2×

Conditions

Temperature
40 °C

Procedure

356 mg (2.2 mmol) of N,N'-carbonyldiimidazole in 3 ml of tetrahydrofuran are added to 200 mg (2 mmol) of 4-pentynoic acid in 2 ml of tetrahydrofuran at ambient temperature. The mixture is stirred at 40° C. for 1 hour. 363 mg (1.5 mmol) of 4-[4-(2-oxazolin-2-yl)benzylidene]piperidine are then added and the mixture is stirred at 40° C. for a further 2 hours. The reaction solution is then evaporated down and the residue is purified by column chromatography (Silica gel; ethyl acetate). 320 mg (66% of theory) of the title compound of melting point 118° C. are obtained.

Workup

  1. stirringthe mixture is stirred at 40° C. for a further 2 hours
  2. customThe reaction solution is then evaporated down
  3. customthe residue is purified by column chromatography (Silica gel; ethyl acetate)

Sources & evidence

ORD record
ord-4f05795ae2204b098ebe7eb191bc366d
Source dataset
uspto-grants-1995_11
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US05466687

Reaction notes

Loading…

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes